JPMorgan Chase: Are Banks Cheap or Value Traps in a Higher-for-Longer World?

JPMorgan is the best bank in America. That's been true for a decade. It's also not what you're paying me to tell you. What you need to know is whether, at 12.2x forward earnings in a regime where the Fed can't cut and the yield curve is steepening for the wrong reasons, banks are cheap — or whether cheap is the correct price.

Here's the market's mistake: banks look cheap because earnings look strong. But those earnings still reflect peak-cycle credit quality. The 12.2x P/E assumes the E is durable. It isn't — not with oil threatening margins, claims ticking up, and the Fed unable to ease. When credit normalizes, the E drops, and the stock that looked like 12x turns out to have been 15x or 16x all along. That's the value trap.

To see this clearly, you need to understand how a bank actually makes money. Not the stock — the business. The gap between "this looks cheap on a screener" and "this is actually mispriced" runs through four banking-specific metrics that most generalist investors never examine.

---

NIM: The Transmission Mechanism

Net interest margin is the single metric that explains more of a bank's earnings power than anything else. It measures the spread between what a bank earns on its assets (loans, securities) and what it pays on its liabilities (deposits, borrowings). JPM's NIM is 2.259%.

That number in isolation tells you very little. What matters is direction and driver. The yield curve is steepening — 10-year minus 3-month at +0.53%, Z-score +1.64, well above its 12-month average. Textbook analysis says: steepening curve, NIM expansion, buy banks.

This isn't textbook steepening. The curve is widening because the long end is selling off on inflation fears — not because the front end is dropping as the Fed eases. When steepening is "term premium rising" rather than "Fed cutting," the NIM uplift is smaller and less durable. The bank earns slightly more on new long-duration assets, but its funding cost isn't falling. Deposit competition is intensifying with the Fed on hold at 3.64% and money market funds offering competitive yields.

Not all steepening is equal. A curve that widens because the Fed is easing gives you both sides — higher asset yield, lower funding cost. A curve that widens because inflation expectations are rising gives you only one side, and threatens the other.

---

ROTCE: Why JPM Deserves the Premium

Return on tangible common equity is how you determine whether a bank deserves to trade above book value. The math is simple: if a bank earns more than its cost of equity on its tangible capital, it should trade above 1.0x book. The further above, the higher the justified multiple.

JPM's ROTCE is 18.75%. The cost of equity for a large-cap bank in the current rate environment is roughly 10-11%. JPM is earning nearly double its cost of capital. Using the standard approximation — price-to-book should roughly equal ROTCE divided by cost of equity — you get a justified P/B of approximately 1.7-1.9x. JPM trades at 2.26x. That means the market is pricing in not just today's profitability, but an expectation that it sustains.

Is that expectation warranted? This is where the analysis gets interesting. JPM's ROTCE advantage over the median large-cap bank (which runs closer to 12-14%) comes from three structural sources: scale advantages in investment banking fees, a deposit franchise that funds loans cheaply, and operating leverage from technology investment that smaller banks cannot replicate. These aren't cyclical advantages. They're moat.

But even fortress-quality franchises are cyclical at the earnings level. An 18.75% ROTCE assumes benign credit costs, healthy capital markets activity, and stable NIM. If credit costs normalize and NIM compresses simultaneously — which is exactly what happens in a late-cycle slowdown — ROTCE can drop to 14-15% for even the best banks. At 15% ROTCE, the justified P/B drops to roughly 1.4-1.5x. That's a 30-35% downside from the current 2.26x.

This is not an overvaluation call — it's a conditional premium. You're paying for sustained excellence. If the macro delivers a soft landing, you own a high-quality compounder at a reasonable price. If the macro delivers a credit cycle, you're paying a premium into deteriorating fundamentals.

---

Fee Income: The Diversification Buffer

Here's what separates JPM from most banks in this conversation: 45.42% of its revenue comes from fees, not interest income. That's investment banking, asset management, trading, treasury services, and card fees.

Why does this matter? Because when the NIM story gets difficult — and in a higher-for-longer world with deposit competition, it will — fee income provides a floor. JPM's investment banking franchise is the largest in the world. Its asset management arm benefits from rising asset prices. Its card business generates fee revenue that's largely independent of the rate cycle.

For a regional bank running 80% net interest income, a NIM compression cycle is existential. For JPM, it's a headwind to one business line while other lines can partially offset. This is the structural argument for the quality premium. It's also why comparing JPM's P/E to a regional bank's P/E and concluding "JPM is expensive" is an analytical error. You're comparing a diversified financial franchise to a levered interest rate bet.

---

The Credit Cycle Question

This is the part of the analysis that most bank bulls skip, and it's the part that matters most.

JPM's current credit metrics — non-performing loans, net charge-offs, reserve coverage — are described as "good" in the sector analysis. But "good" in the context of where we are in the cycle is exactly when you should be most cautious. Credit metrics are a lagging indicator. They look best right before they turn.

Here's the chain: oil at $97 feeds into corporate margins. Companies that can't pass through cost increases start cutting headcount. Initial claims are at 224,000 — ticking up from 219,000 two weeks ago. If claims move toward 250,000, it signals the labor market is absorbing the oil shock. If the labor market absorbs it, consumer credit quality starts to crack. When consumer credit cracks, bank provision expenses spike. For a bank with JPM's loan book size, a move from "good" credit quality to "normalizing" credit quality can cost $3-5 billion in annual pre-tax earnings. That alone would push forward EPS from $23.49 toward the $20-21 range.

I'm not predicting this. I'm describing the mechanism — and it's the single most important variable in the entire analysis. Everything else in this note is secondary to whether credit costs stay benign or normalize.

---

Deposit Beta: The Hidden Variable

Deposit beta measures how much of a rate change gets passed through to depositors. High beta means the bank has to share rate increases with depositors, squeezing NIM. Low beta means the bank keeps more of the benefit.

JPM's deposit beta this cycle: approximately 62%. Better than many peers, but structurally higher than pre-2022 norms. With the Fed on hold at 3.64%, money market funds offering competitive rates, and consumer awareness of rate alternatives at an all-time high, deposit betas stay elevated. The era of banks holding trillions in near-zero-cost deposits while earning 4-5% on assets is over for this cycle.

The NIM story is not "rates are high, buy banks." Rates are high — but so is the cost of funding. The spread is what matters, and the spread is narrower than the headline rate suggests.

---

The Regime Verdict

Pull all of this together.

The #1 driver of the entire thesis is credit cycle risk mispriced by current earnings. Everything else — NIM, deposit beta, curve shape — is secondary. If credit stays benign, JPM earns through and the premium holds. If credit turns, the earnings that justify the multiple evaporate first.

JPM is a high-quality franchise trading at a fair price — not cheap, not expensive, conditional on the macro. The 18.75% ROTCE justifies the premium book value. The 45% fee income ratio provides diversification that peers can't match. The balance sheet is fortress-quality.

But the regime is not a bank-friendly regime. The yield curve is steepening for the wrong reason (term premium, not easing). Credit spreads at 1.14% are pricing perfection. The oil shock is a threat to both consumer credit quality and corporate margins. And the Fed's inability to cut means the front end stays high, keeping deposit costs elevated and limiting the NIM uplift from curve steepening.

The Goldilocks regime at 67% confidence says: the economy is fine, banks earn through, hold your position. The fragility of that regime — oil threatening inflation expectations, the Fed boxed in — says: if this breaks, banks are in the first wave of de-rating.

---

Positioning

JPM is a hold for investors who own it as a quality compounder. The franchise quality is real and durable. At 12.2x forward earnings, you're not paying a dangerous price.

It is not a new buy for investors looking to add bank exposure. The risk-reward at this point in the cycle, with credit spreads this tight and the Fed this constrained, does not favor initiating new positions in financials. If you want bank exposure, wait for one of two triggers: either credit spreads widen to 150bp+ (meaning you're being paid for risk), or the Fed begins easing (meaning NIM expansion is real, not theoretical).

For portfolio context: this is not the time to rotate from tech into banks as a "value" play. That trade assumes rates help banks and hurt tech. In reality, the current rate environment is ambiguous for both — it helps bank NIM slightly but hurts credit quality; it pressures tech multiples but doesn't impair tech earnings. The cleaner expression of this regime is not banks. It's the energy overweight I discussed in this week's macro brief.

Verdict: Hold if you own it. Do not initiate. The franchise is exceptional. The cycle is not your friend.

---

Levels that matter: Forward EPS revised below $21.00 (credit cycle starting, trim) · ROTCE sustained above 20% (quality confirmed, hold with conviction) · Baa-10Y spreads above 150bp (credit pricing risk, potential entry point) · Initial claims 4-week MA above 250,000 (consumer credit at risk) · Fed begins easing cycle (NIM expansion becomes real, upgrade trigger)